Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 365 participants.

Also called NCT01652729

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 365 participants (enrolled count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01652729
Other papers using this trial's data
  • Efficacy and safety of autoinjected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study Diabetes, obesity & metabolism, 2017-07 DOI, PubMed 28205322, PMC5485171 PubMed links an erratum for this paper. Erratum: PMID 28834343 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01652729. Randomized; no masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2015-04-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
Acronym
DURATION-NEO-2
Condition
Diabetes Type 2
Intervention (Drug)
Exenatide once weekly suspension
Intervention (Drug)
Sitagliptin
Intervention (Drug)
Placebo
Lead sponsor
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct01652729
Content hash
6c1a0126e9156b3c5dc82eea5751893ebee6f4c239f7c6e1a61a2cf2a1fa3590